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Diabetes mellitus with abnormal glucose concentration is associated with changes in hemorheological 
properties, endothelial function, and platelets hyperactivity. Disturbances may significantly 
be responsible for diabetes-related vascular complications. In this study, hemorheological and 
hemodynamic properties were measured according to diabetic duration after streptozotocin treatment 
in rats. For ex vivo measurements, an extracorporeal model was adopted. Flow rate and blood viscosity 
were measured using a microfluidic device. Erythrocyte aggregation and morphological parameters 
of erythrocytes were measured by modified erythrocyte sedimentation rate and the phase-contrast 
holography under in vitro conditions. The platelet aggregation and mean pressure in the femoral 
artery were estimated under ex vivo conditions. Hemorheological properties including blood viscosity, 
erythrocyte aggregation and shape parameters for the control group are significantly different with 
those for diabetic groups. The changes with respect to diabetic duration were relatively unnoticeable. 
However, the platelet aggregation is strongly dependent on the diabetic duration. Based on these 
results, hyperglycemia exposure may induce hemorheological variations in early stages of diabetes 
mellitus. High platelet aggregation may become more pronounced according to the diabetic duration 
caused by variations in hemorheological properties resulting in endothelial dysfunction. This study 
would be helpful in understanding the effects of diabetic duration on biophysical properties.
Diabetes mellitus is characterized by disordered metabolism and high hyperglycemia resulting from either 
low insulin level or high insulin resistance. Diabetes mellitus is associated with abnormal endothelial function, 
increase of arterial stiffness, platelet hyper-reactivity and hemorheological changes1–3. These resultant distur-
bances may play a critical role in the etiology of diabetes-related vascular complications, including arteriosclero-
sis, cardiac autonomic neuropathy and myocardial infarction4,5.
Among the variations, the viscosity increase of both plasma and whole blood caused by marked changes in 
hemorheological parameters, such as hematocrit, plasma proteins, erythrocyte aggregation, and deformability, 
can lead to the development of microvascular complications6–8. Specifically, hemorheological changes contribute 
to the production of vasoactive materials, such as nitric oxide (NO), prostacyclin, and endothelin, by changing 
shear stress on the endothelial cells9. The relationship between blood viscosity and peripheral vascular resistance 
was reported to be mediated by NO production10.
In previous studies using diabetic models, it was demonstrated that hyperglycemia leads to hyperaggrega-
tion and low deformability of erythrocytes by changing hemoglobin and membrane proteins of erythrocyte, and 
serum proteins (fibrinogen and globulins)3,11. Such hemorheological changes are implicated in the progression of 
retinal failure in diabetic retinopathy and renal failure in diabetic nephropathy.
Endothelial dysfunction mainly results from imbalance between reduced bioavailability of NO and abundant 
formation of reactive oxygen species (ROS) in the vascular wall. This dysfunctional phenomenon is acceler-
ated in diabetics12. Impaired endothelial functions are observed in the very early stages of diabetes mellitus and 
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hyperglycemia13. Given that NO and prostacyclin are inhibitors of platelet aggregation and leukocyte activation, 
the reduced bioavailability of NO in diabetes may result in platelet activation1. These activated platelets play a 
critical role in the progression of atherosclerotic lesion formation14. Therefore, a systematic monitoring of hemor-
heological properties such as blood viscosity, platelet adhesion, erythrocyte aggregation, and erythrocyte shape 
would provide a grasp of the pathophysiological features about the diabetes-related vascular complications.
To investigate between hemorheological properties and diabetes mellitus, various assessment techniques was 
adopted including rotational viscometer, ultrasonic diagnostic, erythrocyte sedimentation rate (ESR), filtration, 
3D topography, optical tweezer, and microfluidic devices8,11,15,16. However, rotational viscometer requires a large 
amount of blood samples for repetitive tests. Ultrasonic diagnostic needs calibration procedure with varying flow 
speed and hematocrits, due to dependency of these factors. The ESR results are influenced by the installation 
angle and surface condition of test tubes. Since most techniques used to measure erythrocyte deformability han-
dle single cells, it is difficult to measure statistically-averaged biophysical properties for many cells. In addition, 
they usually measure hemorheological properties under in vitro conditions. External exposure of blood samples 
can modify the aggregability and deformability of erythrocytes17.
For the measurement of biophysical properties under ex vivo condition, a rat extracorporeal loop model, 
circulating blood through an external loop that directly connects artery and vein, was employed in this study18. A 
number of biophysical properties were measured with the lapse of time by inserting a microfluidic device into the 
rat extracorporeal model. Given that the risk of developing vascular complications related with diabetes mellitus 
is associated with the degree and duration of hyperglycemia, we examined the effects of duration of hyperglyce-
mia on biophysical properties, including blood viscosity, flow rate, pressure, degree of erythrocyte aggregation, 
erythrocyte shape, and platelet adhesion using the rat extracorporeal model and other measurement techniques.
Results
Rat conditions. The toxic effect of streptozotocin (STZ) treatment destroys pancreatic beta cells and changes 
physiological conditions of rat model19. Table 1 summarizes the biophysical characteristics for control and dia-
betic groups according to diabetic duration. The weight is gradually decreased in compliance with the duration 
of diabetes. Glucose concentration in blood samples was measured using an Accu-Chek® sensor instrument 
with test strips (Roche Diagnostics, Mannheim, Germany). Blood glucose for the control group is significantly 
lower than that for diabetic groups, but significant statistical difference is not observed among diabetic groups. 
Hematocrits are almost similar among all groups. The measured hematocrit values are relatively higher, compared 
with normal physiological condition20. It may be related with the dehydration of the rat due to a long-operational 
time. The level of fibrinogen in the plasma was measured by fibrinogen ELISA kit (Abcam, Cambridge, MA) in 
accordance with the manufacturer’s instructions. Fibrinogen concentration for the diabetic groups is significantly 
higher than that for control group. The platelet counts were measured by a semiautomated haematology analyzer 
(Medonic CA 620). The platelet numbers for diabetic groups are slightly lower than that for control group.
Ex vivo blood viscosity. Blood viscosity and flow rate were repeatedly measured at intervals of 10 min for a 
total of 30 min after establishing the rat extracorporeal model. In this condition, response time, which is depend-
ent on the flow rate, is less than 20 s. The time for observing the hydrodynamic balancing state is about 2 min. For 
minimization of dilution or blood loss due to ex vivo measurement, phosphate buffered saline (PBS; pH 7.4, Bio 
Solution, Korea) is only delivered at specific measurement instants. A blood sample was collected after 30 min of 
extracorporeal circulation to measure other biophysical properties including blood glucose, hematocrit, viscosity 
curve, aggregation, and erythrocyte shape.
The viscosity of whole blood passing through the rat extracorporeal model was measured under ex vivo con-
dition, as depicted in Fig. 1A. The flow rate of blood was estimated from the velocity profiles (Fig. 1B) measured 
using the micro-PIV technique. Figure 1C shows that the measured velocity profile in the center region of the 
microchannel is somewhat blunt because of the low aspect ratio (H/W1) of the rectangular channel. To measure 
blood viscosity, the hydrodynamic balancing state was induced in the H-shaped microfluidic device by adjusting 
the injection flow rate of PBS solution, as depicted in the bottom insets of Fig. 1D.
Figure 1D shows the flow rate of PBS solution at the hydrodynamic balancing state (QPBSB) and the flow rate of 
blood (QBlood) for the control rat sample. Although both flow rates QPBSB and QBlood slightly increase and decrease 
for 30 min, its variances are not very noticeable. The variation of flow rate may be caused by some external factors 
including anesthetization and environmental stress. By using Eq. (3), blood viscosity (μBlood) can be estimated at 
specific measurement instants (Fig. 1E). Considering the slight variances of QPBSB and QBlood, measured values 
of μBlood seem to be almost similar during the ex vivo measurements. The temporal variation of μBlood is inversely 
Control DM (3 day) DM (7 day) DM (20 day)
Weight (g) 404.2 ± 15.7 364.9 ± 24.0 319.3 ± 38.1 241.9 ± 20.4*
Blood sugar (mg/dL) 67.7 ± 9.3 468.0 ± 49.2* 455.0 ± 41.4* 534.8 ± 39.4*
Hematocrit (–) 0.52 ± 0.01 0.52 ± 0.03 0.52 ± 0.04 0.49 ± 0.02
Fibrinogen (mg/mL) 3.24 ± 0.40 4.94 ± 0.25* 5.10 ± 0.25* 5.38 ± 0.30*
Platelets (× 1000/μ L) 735 ± 33 689.6 ± 54 704 ± 57 644 ± 49
Table 1.  Biophysical characteristics of normal and diabetic rat groups. Each value represents 
mean ± standard deviation. *p < 0.001: significant difference from the control group.
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correlated with that of QPBSB and QBlood, due to shear dependency of blood viscosity. Mean shear rate under ex vivo 
condition is approximately 2600 s−1.
Variation of in vitro blood viscosity. Since the blood viscosity estimated under ex vivo condition depicts 
only the hemorheological property at a specific flow condition, the variation of blood viscosity according to shear 
rate was obtained by changing the flow rate of collected blood sample based on the relation between shear rate 
and flow rate. The input flow rate of a syringe pump was varied from 0.1 to 25 mL/h. Figure 2A shows variation of 
blood viscosity in a normal rat sample with respect to shear rate γ( )

. A number of different fitting equations have 
been used to depict blood viscosity according to shear rate21. Among these equations, the following Carreau 
model was adopted for blood viscosity prediction22.
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where, μ∞, μ0, λ and n represent viscosity values at infinite and zero shear rates, relaxation time, and power 
index, respectively. As expected, a line fitted with Carreau model is well matched with the measured viscosity 
data. A fitting parameter μ0 is depicted by the results in a box plot representation to compare different viscosity 
degree according to the duration of diabetes (DDiabetes) (Fig. 2B). Mean value of μ0 for the control group is signif-
icantly lower than that for the diabetic groups. However, statistical difference between the diabetic groups is not 
observed.
Variation of modified ESR. To determine the extent of erythrocyte aggregation, the modified ESR value 
was measured. Aggregated erythrocytes are easily sedimented by gravity (Fig. 3A). Right panel of Fig. 3A shows 
optical images with respect to time. As expected, the volume of the erythrocyte-depleted plasma (∆V) is gradually 
increased with lapse of time. Different degrees of erythrocyte aggregation between groups were compared by 
calculating VESR (Fig. 3C). Similar to the results of blood glucose and viscosity, VESR values for diabetic groups are 
Figure 1. Experimental system for ex vivo monitoring of biophysical properties. (A) Blood is supplied 
into the extracorporeal fluidic network by connecting an extracorporeal loop to the blood vessels of a rat 
model. The extracorporeal loop consists of a pulse-free chamber (air cavity = 1.5 mL), and H-shaped and 
straight microchannels. The syringe and microfluidic devices were illustrated by the authors using SolidWorks 
software (Dassault Systèmes SolidWorks Corp., USA). (B) Procedure of micro-PIV measurement. The 
H-shaped microchannel has a width (W1) of 3000 μ m and a height (H) of 80 μ m. An instantaneous velocity 
field superimposed on the corresponding flow image is represented in the inset. (C) Axial velocity profile along 
the lateral position (x) of the channel. 3D velocity distribution in the channel and calculation of flow rate (Q). 
(D) Temporal variations in the flow rate of the PBS solution at the hydrodynamic balancing state (QPBSB) and 
blood flow rate (QBlood) measured by using Eq. (2). Microscopic images show hydrodynamic unbalancing and 
balancing states in the H-shaped microchannel. (E) Temporal variation of blood viscosity (μ Blood).
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markedly higher than that for the control group regardless of diabetic duration. The hyperaggregation of erythro-
cytes in diabetic groups can be elucidated by using the depletion theory. Since the osmotic force caused by the 
different concentrations of long-chain macromolecules between surface of erythrocyte and the bulk plasma 
makes adjacent erythrocytes aggregate together, the increased fibrinogen in STZ rat model gives rise to a high 
VESR23,24.
Variation of erythrocyte shapes. The cytoplasmic viscosity of erythrocyte is highly dependent on hyper-
glycaemia. Variation in the membrane lipid-protein interactions may alter viscoelastic properties of erythrocyte 
membrane. These abnormalities in erythrocyte membrane contribute to the changes in morphological features 
of erythrocytes in diabetic groups. The deformability of individual erythrocytes is closely related to the morpho-
logical feature of erythrocytes11. Specifically, the surface area-to-volume ratio of a biconcave disc significantly 
contributes to the degree of deformability25. In order to estimate the deformability of erythrocytes for each group, 
3D shape of erythrocytes was measured by the phase-contrast digital holography. Figure 4 compares 3D mor-
phologies of normal and diabetic erythrocytes. Since the shape changes according to the duration of diabetes are 
not significant, 3D morphology of a diabetic sample at the 20 days diabetic duration is only represented. Diabetic 
erythrocytes have relatively higher cell thickness compared to that of normal erythrocytes. However, significant 
shape changes, such as loss of biconcave shape and echinocyte shape transformation26, are not observed.
To more systematically investigate the morphological changes of erythrocytes, some morphological param-
eters, such as perimeter, 2D area, perimeter-to-2D area ratio, volume, 3D surface, and surface area-to-volume 
ratio, are summarized in Table 2. Perimeter, 2D area, volume, and 3D surface do not show noticeable changes in 
the consideration of their relatively high standard deviations. However, the perimeter-to-area ratio and surface 
area-to-volume ratio for the control group are significantly different with those for diabetic groups. Similar to 
other hemorheological properties, changes in morphological properties between diabetic groups are relatively 
weak with no statistical difference.
Figure 2. Variation of blood viscosity measured under in vitro condition. (A) Variation of blood viscosity 
according to shear rate. A curve fitted with Carreau model is included. (B) Viscosity values at zero shear 
rate (μ0) in the Carreau model are depicted according to duration of diabetes (DDiabetes). The line in the box 
represents median value. (*p < 0.001: significant difference from the control group).
Figure 3. Measured modified ESR values. (A) Schematic of the modified ESR measurement. After loading a 
blood sample in a disposable syringe (1 mL), the syringe is vertically disposed in the inverted position. Typical 
images show the sedimentation of erythrocytes in the blood sample with respect to time (t). The syringe was 
illustrated by the authors using SolidWorks software. (B) Variation of ESR value ( )VESR  according to DDiabetes. 
(*p < 0.001: significant difference from the control group).
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Estimation of platelet aggregation under ex vivo condition. As depicted in Fig. 5A, the degree of 
platelet aggregation was estimated by quantifying the area of adhered platelets in the straight channel under 
ex vivo condition. Temporal variations of the area of adhered platelets were monitored to find the optimal con-
dition in advance of the main experiments. Figure 5B shows extremely severe variation in APlatelet for a diabetic 
rat model with the 30 days diabetic duration. APlatelet slightly increases at the initial state after establishing the rat 
extracorporeal model. Subsequently, the adhered platelets are almost not observed until 20 min later. As depicted 
in insets (Fig. 5B(a–c)), some platelets are rapidly attached in the straight channel after 20 min. Given that large 
platelet aggregates are subjected to large force caused by increased fluidic resistance, large aggregates are suddenly 
detached from the microchannel at around t = 25 min. However, platelets are re-adhered and then the straight 
channel is completely blocked by platelet aggregates at 40 min. Based on this temporal variation of APlatelet, the area 
of platelets APlatelet at 30 min is used as the representative parameter to compare the platelet aggregation between 
the normal and diabetic groups.
Figure 5C shows a box plot representing APlatelet at t = 30 min after the ex vivo measurement according to 
the duration of diabetes (DDiabetes). Unlike other hemorheological properties such as blood viscosity, erythrocyte 
aggregation, and erythrocyte shape, the degree of platelet adhesion for diabetic groups is largely increased with 
diabetic duration DDiabetes. As DDiabetes increases, the standard deviation of APlatelet is also significantly increased. 
Platelet activated by hemodynamic features is primarily mediated by soluble fibrinogen and von Willebrand fac-
tor (vWF) which support both adhesion and aggregation of platelets. Thus, the enhanced fibrinogen and vWF in 
diabetic rat models induce hyper-adhesion of platelets (Table 1)27.
Observation of ex vivo hemodynamic conditions. Mean pressure variation was monitored during the 
ex vivo measurements. The different size of channels in the extracorporeal loop induces different shear rate at a 
certain part of the extracorporeal loop despite of the same flow rate. For reasonable estimation of mean pressure 
in the femoral artery (PArtery), the viscosity value at a specific shear condition fitted by Eq (1) was applied to Eq (5). 
Figure 6A shows temporal variation of PArtery with the lapse of time under ex vivo condition for the control sample. 
Like flow rate results (Fig. 1D), PArtery is slightly increased and then decreased in a 30 min period. A dotted line 
indicates the mean value of PArtery ( )PArtery  during the experiment time. PArtery was used as a parameter represent-
ing the hemodynamic condition for all groups. As depicted in the box plot of Fig. 6B, statistically different ten-
dency of PArtery is not observed for all groups.
Discussion
Considering that glucose is an essential nutrient for body cells, abnormal glucose concentration may have a direct 
influence on the constituents and biochemical properties of blood circulating in vascular networks28,29. In pre-
vious studies, it was found that STZ-induced diabetes mellitus significantly alter lipid composition, mRNA and 
plasma protein levels16,30,31. Specifically, increase in soluble thrombomodulin (sTM), vWF and fibrinogen and 
Figure 4. 3D morphology of erythrocytes. A modified version of common-path diffraction phase microscopy 
was utilized to measure 3D morphology of individual erythrocytes. Overall magnification is approximately 
120 × . Blood sample was diluted in PBS solution with volume ratio of 1:200. Topography of (A) a control and 
(B) diabetic erythrocyte after 20 days from STZ treatment. Color bar indicates the depth of the erythrocyte.
Control DM (3 days) DM (7 days) DM (20 days)
Perimeter (μ m) 20.96 ± 1.11 20.42 ± 0.76 21.33 ± 0.81 20.73 ± 0.75
2D area (μ m2) 44.01 ± 2.40 41.14 ± 3.25** 44.53 ± 2.07 42.38 ± 2.59
Perimeter/Area (μ m−1) 0.48 ± 0.02 0.50 ± 0.02** 0.49 ± 0.02* 0.49 ± 0.01**
Volume (fL) 81.71 ± 12.59 88.88 ± 10.94 88.57 ± 8.26 87.03 ± 9.89
3D surface area (μ m2) 111.20 ± 12.34 107.08 ± 9.07 111.32 ± 8.18 111.20 ± 5.91
Surface area/volume (μ m−1) 1.37 ± 0.10 1.22 ± 0.16** 1.26 ± 0.12** 1.29 ± 0.15*
Table 2.  Morphological parameters of erythrocyte between normal and diabetic groups. Each value 
represents mean ± standard deviation. *p < 0.1, **p < 0.05: significant difference from the control group.
www.nature.com/scientificreports/
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decrease in activated factor XIII have also been reported in STZ diabetic models27. These alterations can induce 
change in hemorheological properties such as viscosity, hematocrit, plasma proteins, erythrocyte aggregation, 
and deformability, and platelet aggregation32.
To investigate variation of hemorheological properties and platelet aggregation according diabetic duration, 
some measurement methods were adopted in the present study. Although ex vivo measurement can offer more 
reasonable data compared with in vitro measurement based on our previous studies17, it is difficult to simulta-
neously measure various hemorheological properties under ex vivo conditions. Therefore, viscosity variation, 
erythrocyte aggregation, and shape were measured by in vitro experiments. Fortunately, platelet adhesion can 
be quantified without significant flow modification when blood flow is similar among ex vivo measurements. To 
check flow conditions of ex vivo measurements, pressures at the femoral artery were compared.
Among these hemorheological properties, blood viscosity has a profound impact on blood circulation. In 
this regard, the variation of viscosity according to shear rate was measured using the H-shaped microchan-
nel. Diabetic rats were found to have relatively high viscosities compared to the control. These results are in 
Figure 5. Quantification of platelet adhesion under ex vivo condition. (A) Procedure for measurement of 
platelet aggregation in the straight channel. Optical images were obtained by high-speed camera with time 
intervals (∆t) of 1 s. Scale bar indicates 100 μ m. To distinguish adhered platelets from the flowing blood, a 
correlation map depicting the correlation coefficient of two consecutive images is obtained. By conducting 
additional image processing techniques, the area of adhered platelets (APlatelet) is obtained. (B) Temporal 
variation of APlatelet for a rat model with 30 days diabetic duration. Correlation maps at 10, 20, 30 min are 
inserted. (C) Variation of APlatelet according to the duration of diabetes DDiabetes. Typical binary images for the 
four groups are included. (*p < 0.005: significant difference from the control group).
Figure 6. Estimation of mean pressure in the femoral artery under ex vivo condition. (A) Temporal 
variation of mean pressure at the femoral artery (PArtery) of the control rat sample, estimated based on the 
pressure drop in the fluidic circuit. The mean pressure ( )PArtery  during the measurement is included. (B) 
Variation of PArtery according to duration of diabetes DDiabetes.
www.nature.com/scientificreports/
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accordance with previous studies conducted on STZ-induced rats16. The increase in blood viscosity is consistently 
observed after 3 days from the STZ treatment. The elevated blood viscosity may be associated with the aggrega-
bility and deformability of erythrocytes3,29.
The ESR has been widely used as a nonspecific indicator of inflammation, because it is mainly affected by 
erythrocyte aggregation. Specific plasma proteins of fibrinogen and globulins form intercellular layer in the 
vicinity of erythrocytes, leading to an aggregating force. Therefore, the increase of these proteins contributes to 
enhanced erythrocyte aggregation in STZ diabetic models33,34. The contribution of the erythrocyte aggregation to 
the increase of the blood viscosity was evaluated by measuring the modified ESR. As expected, the modified ESR 
result exhibits similar variation trends of blood viscosity results according to diabetic duration.
In addition, diabetic state can cause reduced deformability of erythrocytes35,36. The deformability of erythro-
cytes is influenced by three factors: (i) the viscosity of intracellular fluid determined by the presence of hemo-
globin, (ii) the viscoelastic properties of cell membrane, and (iii) the morphological feature of erythrocytes such 
as diameter, concave depth, surface area, and volume. In this study, morphological parameters were intensively 
investigated using phase-contrast digital holography. The erythrocytes suffered from hyperglycemia have dif-
ferent morphology compared to healthy erythrocytes35. It was reported that the perimeter-to-2D area ratio for 
erythrocytes becomes high with relatively low deformability, as the glucose concentration increases37. Similar to 
previous studies, the perimeter-to-2D area ratios for diabetic groups have smaller values than those for the nor-
mal group with high surface area-to-volume ratios. This morphological change in diabetic groups may be resulted 
from lipid alterations of erythrocyte membrane caused by decreased Na+-K+-ATPase activity36,38. However, sig-
nificant variations are not observed among the diabetic groups with different diabetic duration. It signifies that 
the slightly reduced deformability of erythrocytes caused by the morphological shape change is continuously 
maintained after 3 days from the STZ treatment.
A sudden shear acceleration can directly initiate platelet aggregation, independent of biochemical trig-
gers39–41. Therefore, platelets can be activated when they pass through the narrow inlet of the straight channel 
and adhered on the downstream of straight channel. By applying the correlation mapping, platelet aggregation 
can be estimated by measuring the area of adhered platelets. As shown in Fig. 5C, the degree of platelet adhe-
sion and diabetic duration have a positive correlation (R2 = 0.623). Considering the process of platelet aggrega-
tion is dependent on the shear condition42,43, the mean pressure in the femoral artery was also estimated under 
ex vivo conditions to check the shear condition during the measurements of platelet adhesion. The measured 
mean pressures indicate that no significant difference exists among all groups tested in this study. Therefore, shear 
conditions may not have any significant influence on the increase trend of platelet aggregation according to the 
duration of diabetes.
Exposure to hyperglycemia can damage or alter endothelial barrier12. Increases in the blood viscosity and 
erythrocyte aggregation, as well as morphological shape change induced by diabetes mellitus, may also lead to 
endothelial dysfunction by disturbing the blood circulation in microvessels. Impaired endothelial dysfunction 
under diabetic conditions can result in reduced NO bioavailability and abundant ROS formation13. This type of 
imbalance between NO and ROS can lead to platelet aggregation with shape change of platelets, degranulation, 
and rapid surface expression of adhesion molecules44. In addition, the increases of vWF and fibrinogen due to 
endothelial dysfunction was observed in STZ diabetic models (Table 1)27. These proteins support both adhesion 
and aggregation of platelets. Thus, the hyper-adhesion of platelets may become more pronounced according to 
the diabetic duration caused by consistent exposure to hyperglycemia and large variations in hemorheological 
properties resulting in endothelial dysfunction. However, the results of platelet accumulation might be influenced 
by some artifacts caused by extracorporeal circulation of blood. Some portions of the platelet aggregates circu-
lating in the rat model and extracorporeal loop can promote the aggregation of platelets. Thus, the measurement 
time under ex vivo condition is important to quantify the degree of platelet aggregation. Through preliminary 
experimental results, we found that the usage of a rat sample with high diabetic duration (more than 30 days) or 
prolonged experiment (more than 30 min) easily blocked the straight channel due to significant adhesion of plate-
let aggregates. Based on these results, a suitable experimental condition for estimating the platelet aggregation 
and blood pressure at the artery was determined.
Conclusion
In this study, various biophysical properties, such as blood viscosity, erythrocyte aggregation, 3D morphology, 
and platelet aggregation, were measured according to the duration of diabetes under ex vivo and in vitro condi-
tions. Based on these results, hyperglycemia induces variations in hemorheological properties from the very early 
stage of diabetes mellitus. It is caused by alteration of plasma proteins such as sTM, vWF and fibrinogen. These 
variations may lead to the hyper-adhesion of platelets and may be responsible for the diabetic-related vascular 
complications, such as nephropathy, retinopathy, and atherosclerosis in coronary and carotid arteries. Although 
further detailed study is required to examine the relationship between the variations of hemorheological proper-
ties and vascular complications of diabetic patients, we believe that this study would be beneficial in understand-
ing temporal variations of hemorheological properties according to the duration of diabetes.
Methods
Fabrication of microfluidic devices. A rectangular master replica mold (height = 80 μ m) was fabricated 
using microelectromechanical system (MEMS) technologies based on soft lithography and deep reactive-ion 
etching. An H-shaped microfluidic device has two identical side channels with width (W1) of 3000 μ m and length 
of 14.4 mm. A bridge channel connecting both side channels has width of 100 μ m and length of 2.4 mm. A 
straight microchannel has width (W2) of 1 mm and length of 10 mm. To initiate platelet aggregation in the straight 
microchannel, inlet region has narrow width about 100 μ m and the microchannel was coated by collagen based 
on previous studies (Supplementary Fig. 1)40,45. After pouring Polydimethylsiloxane (PDMS; Sylgard 184, Dow 
www.nature.com/scientificreports/
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Corning, USA) on the silicon replica mold, it was cured at 80 °C for 3 h. Thereafter, a PDMS block was peeled 
off from the silicon mold. The inlet and outlet of microchips were made with a puncher of 1.2 mm in diameter. 
After oxygen-plasma treatment (CUTE, Femto Science, Korea), the microfluidic device was finally prepared by 
bonding the PDMS block to a glass substrate.
Microfluidic devices employed for simultaneous measurements of biophysical properties, including blood 
pressure, viscosity, flow rate, and platelet adhesion have several distinctive advantages. First, biophysical prop-
erties of real blood can be directly measured by connecting the microfluidic devices with blood vessels of a rat 
model without noticeable hemorheological changes. The microfluidic devices can measure biophysical properties 
using small amount of sample consumptions. In addition, they do not require any calibration procedures.
Preparation of extracorporeal model using diabetic rat samples. Male Sprague-Dawley rats were 
exposed to a 12/12 reverse-light cycle. Type 1 diabetes with hyperglycemia was induced by intraperitoneal injec-
tion of streptozotocin (STZ; 65 mg/kg in sterile saline) to rat samples under anesthesia with isoflurane and oxy-
gen. Rat samples were fasted for 24 h prior to the STZ injection, and then fasted for another 24 h. They were 
divided into four groups, depending on the duration of diabetes (control, 3, 7 and 20 days).
A rat extracorporeal model was adopted to measure some biophysical properties under ex vivo conditions 
(Fig. 1A)18. All experiments were conducted using 16-week-old rat samples, which were anesthetized with intra-
muscular injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). A PE-50 tube (ID = 0.58 mm, polyethylene 
tube) at one end of the extracorporeal loop was cannulated into the right jugular vein. Exact amount of heparin 
(1500 IU/mL/kg) was precisely injected into the right jugular vein for anticoagulation. After 10 min of heparin 
injection, another PE-50 tube at the other end of the loop was inserted into the left femoral artery. A pulsed-free 
microfluidic device with 1.5 mL air cavity was installed between the femoral artery and the inlet of the H-shaped 
microfluidic device to supply stabilized blood samples. The outlet of the H-shaped microchannel and the inlet of 
the straight microchannel were connected by a Tygon tube (ID = 250 μ m). The blood passing through the extra-
corporeal conduits was returned to the jugular vein of the rat model. The cooling effect caused by the blood circu-
lation through the extracorporeal loop was minimized by installing a heat chamber maintained at 36 °C to 37 °C. 
All experimental procedures were approved by the Animal Care and Ethics Committee of Pohang University of 
Science and Technology, and all methods were performed in accordance with the approved guidelines.
Micro-PIV technique for flow rate measurement. As shown in Fig. 1B, a micro-PIV was used to meas-
ure blood flows in the H-shaped microchannel. The microfluidic devices were mounted on the stage of an optical 
microscope (Nikon, Tokyo, Japan) with 4 × objective lens (NA = 0.1). Optical images of blood flows were con-
secutively acquired using a high-speed camera (FASTCAM SA 1.1, Photron Ltd., San Diego, USA) at a frame rate 
of 5000 fps. Before applying the cross-correlation PIV algorithm to each image pair, the captured images were 
cropped into images of 408 pixels × 320 pixels. The detailed procedures of micro-PIV technique employed in 
the present study were well described in our previous studies46,47. The size of each interrogation window was 16 
pixels × 32 pixels with 50% overlapping. The obtained velocity fields were filtered using a 3 × 3 median kernel. 
Velocity profiles were obtained by averaging the velocity field along the flow direction (y-axis).
Based on our previous study15, the measured velocity information can be postulated to represent the mean 
velocity of erythrocytes in the whole depth, because the depth of correlation (δC = 310 μ m), which expresses the 
depth over which particles contribute to the cross-correlation analysis, is larger than the channel depth under 
present experiment condition. Therefore, the flow rate of blood (QBlood) in the microchannel can be estimated 
using the following equation:
∫= ( ) × ( )Q U x dx H 2Blood 0
W1
where U(x) is the velocity profile at a specific lateral position (x); and W1 and H indicate the width and depth of 
the H-shaped microchannel, respectively.
Viscosity estimation. Blood sample and PBS solution were separately delivered into the two inlets of the 
H-shaped microfluidic device to estimate blood viscosity. The PBS solution was supplied using a syringe pump 
(neMESYS, Centoni Gmbh, Germany) with a 5 mL plastic syringe (BD). When a blood sample does not move 
in the bridge channel (hydrodynamic balancing state), the viscosity of the blood sample (μBlood) can be simply 
estimated based on the following analytical formula:
µ µ=
( )
Q
Q 3Blood PBS
PBS
B
Blood
where, μPBS, and QPBSB denote viscosity, and the flow rate of PBS solution at the hydrodynamic balancing con-
dition, respectively. The viscosity of PBS solution (μPBS) is approximately 1.00 ± 0.05 cP48. Details of viscosity 
estimation procedure were well described in our previous study46.
Modified erythrocyte sedimentation rate measurement. Modified ESR value was measured using a 
1 mL plastic syringe (BD). Based on our previous results, the hematocrit of the blood samples was adjusted to 20% 
for effective measurement of erythrocyte aggregation using the modified ESR value15. After loading blood sample 
(0.9 mL) into a disposable syringe, the syringe was disposed in an inverted vertical posture (Fig. 3A). Snap shots 
of the syringe were continuously captured with a digital camera (D700, Nikon, Japan) at 5 min intervals for 12 h. 
Boundaries between erythrocytes and erythrocyte-depleted plasma were determined by adopting Canny’s 
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method49. ESR value ( )VESR  can be calculated by dividing the volume of erythrocyte-depleted plasma (∆V) by the 
measurement time (t = 12 h).
Phase-contrast digital holography. Whole blood was diluted 1:200 in the PBS solution and then placed 
between slide glass and cover glass. Prepared blood sample was mounted on the stage of an upright microscope 
(Eclipse i50, Nikon) with 40 × objective lens (NA = 0.75). Additional relay optics were used to provide overall 
magnification of 120 × . A modified version of common-path diffraction-related phase microscopy was utilized 
to measure the 3D morphological shape of erythrocytes50. The laser beam (He–Ne laser; λ = 633 nm) is separated 
into two beams by a beam splitter. One beam passes through the test sample and the other beam, which is used 
as the reference beam, passes through a pinhole. A hologram, made by interference between the two beams, was 
captured by a charge-coupled device camera (PCO 2000, 2K × 2K pixel, 7.4 μ m/pixel). An angular spectrum algo-
rithm was employed for numerical reconstruction of hologram images. Perimeter, 2D projected area, 3D surface 
area and volume of erythrocytes were evaluated from the reconstructed phase images. The detailed procedures of 
hologram reconstruction and cell analysis were well described in our previous study51.
Quantification of adhered platelets. Before establishing the rat extracorporeal model, the conduits, 
except for the straight microchannel, were incubated with 2% bovine serum albumin (Sigma, MO) for 1 h at 
room temperature to inhibit platelet deposition and fibrin adhesion. After 1 h, BSA is washed by PBS solution. A 
total of 60 images of blood flow and adhered platelets in the straight microchannel were consecutively acquired 
by the high-speed CMOS camera (FASTCAM SA 1.1) with time interval of 1 s at 30 min after establishing the 
extracorporeal rat model. In order to accurately distinguish the adhered platelets from the flowing blood, a cor-
relation map, labeling the 2D correlation coefficient between small tiles of two consecutive images, was adopted 
(Fig. 5A)52. Each optical image was divided into small tiles of m × n. The 2D correlation coefficient (R) of tiles was 
calculated using the following equation:
( ), = ∑ ( ( , ) − )( ( , ) − )
(∑ ( ( , ) − ) )(∑ ( ( , ) − ) ) ( )
,
, ,
R C C
A i j A B i j B
A i j A B i j B 4
i j
i j
i j i j
2 2
where A and B represent the tiles centered at (Ci, Cj) in two consecutive images, (i, j) is the pixel coordinate of the 
tile, and A and B denote the mean intensity of the tiles A and B, respectively. The size of each tile used in this study 
is 11 pixels × 11 pixels. The correlation maps were converted into binary images by applying the thresholding with 
an optimal value of Otsu’s algorithm. Finally, area for adhered platelets (APlatelet) is estimated by calculating the 
total number of any nonzero pixels in the binary image.
Estimation of mean pressure in the femoral artery. A discrete fluidic circuit of the present extra-
corporeal model is composed of fluidic resistances, air compliance of the pulse-free chamber, and flow rates. By 
adding pressure drops in the fluidic circuits from hydrodynamic balancing pressure in the microfluidic device, 
the mean pressure in the femoral artery (PArtery) can be estimated using the following equation;
pi
µ µ µ=



∆
+
∆ ∆ 


+
( )
P Q L
D
L
D
L
D
P128
5
Artery
Blood
n
n
PBS
B
1
1
1
4 2
2
2
4
n
4
where, μn, Ln and Dn represent the blood viscosity, characteristic length and hydraulics diameter at a certain 
part of the extracorporeal network (Supplementary Fig. 2). PPBSB denotes the hydrodynamic balancing pressure 
in the H-shaped microchannel. In the prediction of blood pressure, it is assumed that blood is circulated in the 
extracorporeal network without bleeding and no change in the fluidic resistance. However, due to accumulation 
of platelet aggregates in the straight channel, the pressure in the artery (PArtery) would be somewhat overestimated.
Statistical analysis. Results in each group indicate the mean value evaluated from five test samples. The 
statistical analysis of the data was carried out by Student t-test between control and diabetic groups. The statistical 
analysis among diabetic groups are not observed in all Tables and Figures.
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